Lucentis, Injektionslösung zur intravitrealen Anwendung in Durchstechflasche
7680576640027
CH-57664
Injektionslösung
Associated product:
LUCENTIS 2.3 mg/0.23ml av accessoire flac 0.23 ml
1 / 3
google
Article details
- Package size
- 0,23 ml
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Injektionslösung
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
ranibizumabum
|
10.0 MG | Substance | Wirkstoff (Principe actif) |
|
trehalosum dihydricum
|
- | Substance | HNIDK |
|
histidini hydrochloridum monohydricum
|
- | Substance | HNIDK |
|
histidinum
|
- | Substance | HNIDK |
|
polysorbatum 20
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Authorization holder
Novartis Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 57664
- Drug name
- Lucentis, Injektionslösung zur intravitrealen Anwendung in Durchstechflasche
- Galenic form
- LSINJ
- ATC Code
- S01LA04
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 25/08/2006
- Authorization expiration date
- 31/12/9999
- IT Number
- 11.99.0.
- Domain
- Human medicine
Package details
- Description (FR)
- LUCENTIS 2.3 mg/0.23ml av accessoire flac 0.23 ml
- Description (DE)
- LUCENTIS 2.3 mg/0.23ml m Zubehör Durchstf 0.23 ml
- Market launch
- 25/08/2006
- Narcotic (BTM)
- No